The blog of the 2009 – 2017 Presidential Commission for the Study of Bioethical Issues

Posts in category: Medical Countermeasures

Compensating Participants Injured in Pediatric Medical Countermeasure Research

In its recent report, Safeguarding Children: Pediatric Medical Countermeasure Research, the Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission) revisited the issue of compensation for research-related injury—an issue first addressed in its December 2010 report, Moral Science: Protecting Participants in Human Subjects Research. In Safeguarding Children, the Bioethics Commission reaffirmed the conclusion […]

Share this article

Bioethics Commission Develops Ethical Framework—Guidance for National-Level Review of Higher Risk Pediatric Research Protocols

The central tenet of pediatric research ethics is that it should not pose greater than minimal risk (or the risks of daily life) to participants, and, when greater risk cannot be avoided in research, there must be a commensurate potential for direct benefit to pediatric participants or benefit to an identifiable class of children. Only […]

Share this article

What is anthrax vaccine adsorbed and what do we know about it?

Anthrax is an infection of the skin, intestinal tract, or lungs caused by exposure to spores of the bacterium, Bacillus anthracis. Although several types of antibiotics are approved by the U.S. Food and Drug Administration (FDA) to prevent and treat anthrax, such antibiotics do not provide long-term protection against the persistence of dormant spores. Data […]

Share this article

In Safeguarding Children, Commission provides guidance for application of section 407

Most pediatric research can be approved by an institutional review board (IRB) if it poses only minimal risk, offers the prospect of direct benefit, or yields vitally important generalizable information about the participants’ condition. When a pediatric research proposal does not fit within these confines, to move forward, it must be elevated to national-level review […]

Share this article

Community Engagement in Pediatric Medical Countermeasure Research

The Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission) recently published its report, Safeguarding Children: Pediatric Medical Countermeasure Research, in which it reviews the ethical considerations for conducting research on medical interventions that would be used to protect children in the event of a bioterror attack—also known as “medical countermeasures” (MCM). One […]

Share this article

Revisiting Research Ethics

In its most recent report, Safeguarding Children: Pediatric Medical Countermeasure Research, the Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission) builds on its prior work concerning human subjects research protections.  In November 2010, President Obama charged the Bioethics Commission to conduct a thorough review of current protections for research participants.  The Bioethics […]

Share this article

Core Principles in Safeguarding Children

In 1978 the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (the National Commission) published the Belmont Report, which established the three central principles of human subjects research protections—respect for persons, beneficence, and justice—and implicitly endorsed a fourth principle, democratic deliberation. These foundational principles guided the Presidential Commission for the […]

Share this article

What Is “Minimal Risk” For Research with Children?

Conducting clinical research with children is necessary to ensure that children are prescribed safe and effective medications.  However, children are legally prohibited and ethically unable to consent to clinical research.  As a result, clinical research with children requires more careful ethical analysis and oversight. According to federal regulation, clinical research with children is generally acceptable […]

Share this article

What are Medical Countermeasures?

The Presidential Commission for the Study of Bioethical Issues (the Bioethics Commission) recently published a report, Safeguarding Children: Pediatric Medical Countermeasure Research, addressing the ethical considerations in conducting clinical trials of medical countermeasures (MCMs) with children. The Bioethics Commission received its charge for this report from the U.S. Department of Health and Human Services Secretary, […]

Share this article

Multiple steps must be taken before ethical pediatric anthrax vaccine trials can be considered

Today the Presidential Commission for the Study of Bioethical Issues concluded that the federal government would have to take multiple steps, including additional research in adults, before anthrax vaccine trials with children could be ethically considered by the U.S. government.  In its report released today, Safeguarding Children: Pediatric Medical Countermeasure Research, the Bioethics Commission responded to […]

Share this article

About blog.Bioethics.gov

This is a space for the members and staff of the 2009 -2017 Presidential Commission for the Study of Bioethical Issues to communicate with the public about the work of the commission and to discuss important issues in bioethics.

As of January 15th, 2017 this blog will no longer be updated but continues to be available as an archive of the work of the 2009-2017 Presidential Commission for the Study of Bioethical Issues

Learn more about the 2009 - 2017 Presidential Commission for the Study of Bioethical Issues.